Acute coronary syndromes

Ticagrelor Monotherapy after 3 Months: Is the Current Strategy Worth Changing?

Dual antiplatelet therapy (DAPT) after PCI with DES has shown noticeable reduction of thrombotic events, especially in...

solaci - 21 March, 2022

Acute coronary syndromes

Abbreviated DAPT in ACS: The End of Clopidogrel Monotherapy?

Compared with patients with chronic coronary syndromes, patients with acute coronary syndromes (ACS) are more likely to...

solaci - 21 March, 2022

Acute coronary syndromes

Zwolle Score: Can a Risk Score Decide Where STEACS Patients Should Stay?

The mortality of ST-segment elevation acute coronary syndromes (STEACS) has decreased thanks to improved reperfusion times (fibrinolysis...

solaci - 16 March, 2022

Acute coronary syndromes

Is Epinephrine Superior to Adenosine in No-REFLOW?

In patients with acute coronary syndrome, no-reflow prevalence is 32%. Different drugs—such as adenosine, verapamil, nitroprusside, or...

solaci - 9 March, 2022

Acute coronary syndromes

Acute Coronary Syndrome: What Is Safer, Antiaggregant Monotherapy or De-Escalation?

For several years it has been shown that 12-month dual antiplatelet therapy (DAPT) is mandatory for patients...

solaci - 9 March, 2022

Acute coronary syndromes

IVUS in Acute Coronary Syndrome: A New Requirement?

The use of intravascular ultrasound (IVUS) has seen exponential growth across registries over the years, combined with...

solaci - 7 March, 2022

Acute coronary syndromes

Bypass Grafting and Native Coronary Artery Disease Activity

Positron emission tomography (PET) with F sodium fluoride (F-NaF) allows for the assessment of microcalcification activity (MA)...

solaci - 4 March, 2022

Acute coronary syndromes

Cangrelor: Additional Research Findings Not Translating into Clinical Practice

The potent and fast endovenous platelet inhibition provided by Cangrelor reduces ischemic events early in the course...

solaci - 27 January, 2022

Acute coronary syndromes

Ticagrelor Monotherapy after 3 Months: Is the Current Strategy Worth Changing?

Abbreviated DAPT in ACS: The End of Clopidogrel Monotherapy?

Zwolle Score: Can a Risk Score Decide Where STEACS Patients Should Stay?

Is Epinephrine Superior to Adenosine in No-REFLOW?

Acute Coronary Syndrome: What Is Safer, Antiaggregant Monotherapy or De-Escalation?

IVUS in Acute Coronary Syndrome: A New Requirement?

Bypass Grafting and Native Coronary Artery Disease Activity

Cangrelor: Additional Research Findings Not Translating into Clinical Practice

Últimas Noticias

PULSE Registry Subanalysis: Radial vs. Femoral Secondary Access

Direct Oral Anticoagulants for Ventricular Thrombus After STEMI

TRILUMINATE: Liver and Kidney Failure in Tricuspid Valve Edge-to-Edge Repair

Noticias Institucionales

Cuba Sessions 2025 | Young Interventional Cardiologists Contest

Hemodynamics and Interventional Cardioangiology Hybrid Training Course SOLACI-CACI

Check out the best images of the El Salvador 2024 Sessions

Accesos